Medical News Today -
18 Dec 2013 12:00
Proteins called fibroblast growth factor receptors (FGFRs) have been implicated in the development of pancreatic cancer, which remains difficult to treat. Researchers at Roswell Park Cancer Institute (RPCI) have now confirmed that FGFRs can be used as treatment targets in preclinical studies, and have identified certain molecular characteristics that could be useful in developing personalized treatments for patients with pancreatic cancer. Study results have been published online first in the Br...
Share this Article